Ganirelix Acetate Injection
Product Images NDC 65219-028

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ganirelix Acetate (NDC 65219-028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Gan06 0001 01)

Chemical structure of the active ingredient Ganirelix Acetate showing its peptide sequence and molecular composition.*

FDA Label Image

Fresenius Kabi Logo (Gan06 0001 02)

FDA Label Image

Principal Display Panel – 250 Mcg/0.5 mL (Carton)

The packaging label for Ganirelix Acetate Injection 250 mcg/0.5 mL shows a single-dose sterile prefilled syringe for subcutaneous use. The label highlights the product name, strength, and dosage form with usage instructions and storage conditions. Manufactured for Fresenius Kabi USA, LLC, the label includes barcode, NDC 65219-028-05, and company branding.*

FDA Label Image

Principal Display Panel – 250 Mcg/0.5 mL – Syringe Label (Gan06 0001 04)

Label for Ganirelix Acetate Injection 250 mcg/0.5 mL in a single-dose sterile prefilled syringe with a 27 gauge x 1/2 inch needle. Indicates subcutaneous use and storage instructions to discard unused portion and protect from light. Manufactured for Fresenius Kabi USA, LLC, Lake Zurich, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.